Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra

Simonetta Palleschi, Paolo M Ghezzi, Giuseppe Palladino, Barbara Rossi, Marino Ganadu, Domenica Casu, Maria Cossu, Giovanni Mattana, Antonio Maria Pinna, Bruno Contu, Tonina Ghisu, Alessandro Monni, Luana Gazzanelli, Maria Cristina Mereu, Franco Logias, Mario Passaghe, Alessandro Amore, Piergiorgio Bolasco, Sardinian Study Group, Irene Sitzia, Marialuisa Caiazzo, Luciangela Calvisi, Angelo Piras, Annalisa Sini, Emiliana Sulis, MariaRosaria Scalas, Pierluigi Spiga, Andrea Martorana, Sabina Fancello, Elisa Loiacono, Luisa Sereni, Simonetta Palleschi, Paolo M Ghezzi, Giuseppe Palladino, Barbara Rossi, Marino Ganadu, Domenica Casu, Maria Cossu, Giovanni Mattana, Antonio Maria Pinna, Bruno Contu, Tonina Ghisu, Alessandro Monni, Luana Gazzanelli, Maria Cristina Mereu, Franco Logias, Mario Passaghe, Alessandro Amore, Piergiorgio Bolasco, Sardinian Study Group, Irene Sitzia, Marialuisa Caiazzo, Luciangela Calvisi, Angelo Piras, Annalisa Sini, Emiliana Sulis, MariaRosaria Scalas, Pierluigi Spiga, Andrea Martorana, Sabina Fancello, Elisa Loiacono, Luisa Sereni

Abstract

Background: Hemodiafiltration with on-line endogenous reinfusion (HFR) is an extracorporeal dialytic method that combines diffusion, convection and adsorption. HFR-Supra (HFR-S) is a second-generation system with increased convective permeability and adsorption capability. Previous studies suggested that HFR reduces oxidative stress compared to standard haemodialysis. The principal aim of the present study was to compare antioxidant vitamins behavior and oxidative status of hemodialysis patients treated with HFR and HFR-S.

Methods: The study was designed as a multicenter, randomized, crossover trial. Forty-one patients were recruited from 19 dialysis centers and after a 4-month washout stabilization period in on-line hemodiafiltration (ol-HDF), each patient was randomized to a sequence of treatments (HFR-S followed by HFR or viceversa) with each treatment applied over 6 months. Plasma levels of Advanced Oxidation Protein Products, Total Antioxidant Status, vitamins C, A and E and their ligands (Retinol Binding Protein and total lipids) were measured at baseline and at the end of each treatment period.

Results: Results show that the higher convective permeability of HFR-S with respect to HFR did not produce additional beneficial effects on the patients' oxidative status, a slight decrease of both Vitamin A and Retinol Binding Protein being the only difference registered in the long-term. However, as compared to ol-HDF, both the re-infusive techniques allowed to reduce the intradialytic loss of Vitamin C and, in the long-term, improve the patients' oxidative status and increase Retinol Binding Protein plasma values. No significant differences were found between the Vitamin C concentration of pre- and post cartridge UF neither in HFR-S nor in HFR showing that the sorbent resin does not adsorb Vitamin C.

Conclusion: HFR-S and HFR are almost equivalent in term of impact on antioxidant vitamins and oxidative status of hemodialysis patients. Nonetheless, as compared to ol-HDF, both treatments produced a sensible sparing of Vitamin C and may represent a new approach for reducing oxidative stress and related complications in dialysis patients. Long-term effects of re-infusive treatments on patients' cardiovascular morbidity and mortality need to be evaluated.

Trial registration: ClinicalTrials.gov Identifier NCT01492491 , retrospectively registered in 10 December 2011.

Keywords: Adsorption; Antioxidants; HFR; Hemodiafiltration; High permeability; Oxidative stress; Vitamins.

Figures

Fig. 1
Fig. 1
Schematic representation of HFR
Fig. 2
Fig. 2
Study flow-chart
Fig. 3
Fig. 3
Reduction ratios of the studied variables at the end of ol-HDF (n = 41), HFR-S (n = 50) and HFR (n = 50) dialysis sessions. For AOPP and TAS the numbers of studied sessions are 30, 28 and 32 for ol-HDF, HFR-S and HFR, respectively. Each dialysis session at each time of the study was included in the analysis. Data are expressed as means ± SE (error bar). * = p < 0.01 vs ol-HDF; # = p < 0.05 vs ol-HDF; ° = p < 0.01 vs HFR-S; ANOVA (RBP, Vitamin A, Vitamin E) or ANCOVA (Vitamin C, TAS, AOPP)
Fig. 4
Fig. 4
Comparison between the vitamin C levels of pre- and post-cartridge UFs during HFR-S and HFR dialysis sessions. Dotted line = identity line

References

    1. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol. 2004;24:469–473. doi: 10.1016/j.semnephrol.2004.06.026.
    1. Handelman GJ. Vitamin C, deficiency in dialysis patients--are we perceiving the tip of an iceberg? Nephrol Dial Transplant. 2007;22(2):328–331. doi: 10.1093/ndt/gfl534.
    1. Holden RM, Ki V, Morton AR, Clase C. Fat-soluble vitamins in advanced CKD/ESKD: a review. Semin Dial. 2012;25:334–343. doi: 10.1111/j.1525-139X.2012.01084.x.
    1. Raimann JG, Levin NW, Craig RG, Sirover W, Kotanko P, Handelman G. Is vitamin C intake too low in dialysis patients? Semin Dial. 2013;26:1–5. doi: 10.1111/sdi.12030.
    1. Zhang K, Dong J, Cheng X, Bai W, Guo W, Wu L, Zuo L. Association between vitamin C deficiency and dialysis modalities. Nephrology (Carlton) 2012;17:452–457. doi: 10.1111/j.1440-1797.2012.01595.x.
    1. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant. 2002;17:422–427. doi: 10.1093/ndt/17.3.422.
    1. Dashti-Khavidaki S, Talasaz AH, Tabeefar H, Hajimahmoodi M, Moghaddam G, Khalili H, et al. Plasma vitamin C concentrations in patients on routine hemodialysis and its relationship to patients’ morbidity and mortality. Int J Vitam Nutr Res. 2011;81:197–203. doi: 10.1024/0300-9831/a000065.
    1. Deicher R, Ziai F, Bieglmayer C, Schillinger M, Horl WH. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol. 2005;16:1811–1818. doi: 10.1681/ASN.2004100850.
    1. Lu L, Erhard P, Salomon RG, Weiss MF. Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial. Am J Kidney Dis. 2007;50:305–313. doi: 10.1053/j.ajkd.2007.05.001.
    1. Panichi V, Rosati A, Paoletti S, Ferrandello P, Migliori M, Beati S, et al. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial. Blood Purif. 2011;32:7–14. doi: 10.1159/000321369.
    1. Vahlquist A, Peterson PA, Wibell L. Metabolism of the vitamin A transporting protein complex. I. Turnover studies in normal persons and in patients with chronic renal failure. Eur J Clin Invest. 1973;3:352–362. doi: 10.1111/j.1365-2362.1973.tb00362.x.
    1. Espe KM, Raila J, Henze A, Krane V, Schweigert FJ, Hocher B, et al. Impact of vitamin A on clinical outcomes in haemodialysis patients. Nephrol Dial Transplant. 2011;26:4054–4061. doi: 10.1093/ndt/gfr171.
    1. Kalousova M, Kubena AA, Kostirova M, Vinglerova M, Ing OM, Dusilova-Sulkova S, et al. Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis. 2010;56:513–521. doi: 10.1053/j.ajkd.2010.03.031.
    1. Dhondt A, Vanholder R, Van BW, Lameire N. The removal of uremic toxins. Kidney Int Suppl. 2000;76:S47–S59. doi: 10.1046/j.1523-1755.2000.07606.x.
    1. den Hoedt CH, Bots ML, Grooteman MP, van der Weerd NC, Mazairac AH, Penne EL, et al. Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis. Kidney Int. 2014;86:423–432. doi: 10.1038/ki.2014.9.
    1. Filiopoulos V, Hadjiyannakos D, Metaxaki P, Sideris V, Takouli L, Anogiati A, Vlassopoulos D. Inflammation and oxidative stress in patients on hemodiafiltration. Am J Nephrol. 2008;28:949–957. doi: 10.1159/000142724.
    1. Wratten ML, Ghezzi PM. Hemodiafiltration with endogenous reinfusion. In: Ronco C, Canaud B, Aljama P, editors. Contribution to Nephrology. Basel: Karger AG; 2007. pp. 94–102.
    1. De Nitti C, Giordano R, Gervasio R, Castellano G, Podio V, Sereni L, et al. Choosing new adsorbents for endogenous ultrapure infusion fluid: performances, safety and flow distribution. Int J Artif Organs. 2001;24:765–776.
    1. Formica M, Morosetti M, Usberti M, Brognoli M, De Simone W, Zito B, et al. Clinical experience in HFR with a new resin-only sorbent cartridge. G Ital Nefrol. 2004;21(Suppl 30):S71–S74.
    1. Wratten ML, Sereni L, Lupotti M, Ghezzi PM, Atti M, Formica M. Optimization of a HFR sorbent cartridge for high molecular weight uremic toxins. G Ital Nefrol. 2004;21(Suppl 30):S67–S70.
    1. Riccio E, Cataldi M, Minco M, Argentino G, Russo R, Brancaccio S, et al. Evidence that p-cresol and IL-6 are adsorbed by the HFR cartridge: towards a new strategy to decrease systemic inflammation in dialyzed patients? PLoS One. 2014;9:e95811. doi: 10.1371/journal.pone.0095811.
    1. De Simone W, De Simone M, De Simone A, Iannaccone S, Manganelli R, Zito B, et al. Aspects of the on-line hemodiafiltration with regeneration and reinfusion of the ultrafiltrate (HFR): multicenter study. G Ital Nefrol. 2004;21(Suppl 30):S161–S167.
    1. Borrelli S, Minutolo R, De Nicola L, Zamboli P, Iodice C, De Paola A, et al. Intradialytic changes of plasma amino acid levels: effect of hemodiafiltration with endogenous reinfusion versus acetate-free biofiltration. Blood Purif. 2010;30:166–171. doi: 10.1159/000320133.
    1. Aucella F. Hemodiafiltration with endogenous reinfusion. G Ital Nefrol. 2012;29(Suppl 55):S72–S82.
    1. Gonzalez-Diez B, Cavia M, Torres G, Abaigar P, Muniz P. Effect of a hemodiafiltration session with on-line regeneration of the ultrafiltrate on oxidative stress. Comparative study with conventional hemodialysis with polysulfone. Blood Purif. 2008;26:505–510. doi: 10.1159/000163848.
    1. Calo LA, Naso A, Carraro G, Wratten ML, Pagnin E, Bertipaglia L, et al. Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients. Nephrol Dial Transplant. 2007;22:1413–1419. doi: 10.1093/ndt/gfl783.
    1. Calo LA, Naso A, Davis PA, Pagnin E, Corradini R, Tommasi A, et al. Hemodiafiltration with online regeneration of ultrafiltrate: effect on heme-oxygenase-1 and inducible subunit of nitric oxide synthase and implication for oxidative stress and inflammation. Artif Organs. 2011;35:183–187.
    1. Borrelli S, Minutolo R, De Nicola L, De Simone E, De Simone W, Zito B, et al. Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: a multicenter longitudinal study. Hemodial Int. 2014;18:758–766. doi: 10.1111/hdi.12178.
    1. Panichi V, Manca-Rizza G, Paoletti S, Taccola D, Consani C, Filippi C, et al. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial. Nephrol Dial Transplant. 2006;21:756–762. doi: 10.1093/ndt/gfi189.
    1. Monari E, Cuoghi A, Bellei E, Bergamini S, Caiazzo M, Aucella F, et al. Proteomic analisys of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes. J Mater Sci Mater Med. 2014;25:2691–2698. doi: 10.1007/s10856-014-5290-5.
    1. Cuoghi A, Caiazzo M, Monari E, Bellei E, Bergamini S, Sereni L, et al. New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the ‘albumin wall’. J Biomater Appl. 2015;29:1363–1371. doi: 10.1177/0885328214565651.
    1. Alloatti S, Bolasco P, Canavese C, Cappelli G, Pedrini L, Pizzarelli F, et al. Guidelines on water and solutions for dialysis. Italian Society of Nephrology. G Ital Nefrol. 2005;22:246–273.
    1. Bolasco P, Contu A, Meloni P, Vacca D, Murtas S. The evolution of technological strategies in the prevention of dialysis water pollution: sixteen years’ experience. Blood Purif. 2012;34:238–245. doi: 10.1159/000343127.
    1. Bolasco P, Contu A, Meloni P, Vacca D, Galfre A. Microbiological surveillance and state of the art technological strategies for the prevention of dialysis water pollution. Int J Environ Res Public Health. 2012;9:2758–2771. doi: 10.3390/ijerph9082758.
    1. Rossi B, Tittone F, Palleschi S. Set-up and validation of a convenient sampling procedure to timely and effectively stabilize Vitamin C in blood and plasma specimens stored at routine temperatures. Anal Bioanal Chem 2016, in press, doi:10.1007/s00216-016-9560-6
    1. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–1313. doi: 10.1038/ki.1996.186.
    1. Nierenberg DW, Lester DC. Determination of vitamins A and E in serum and plasma using a simplified clarification method and high-performance liquid chromatography. J Chromatogr. 1985;345:275–284. doi: 10.1016/0378-4347(85)80165-1.
    1. Liau LS, Lee BL, New AL, Ong CN. Determination of plasma ascorbic acid by high-performance liquid chromatography with ultraviolet and electrochemical detection. J Chromatogr. 1993;612:63–70. doi: 10.1016/0378-4347(93)80368-E.
    1. Senn SS. Cross-over Trials in Clinical Research. 2nd ed. John Wiley & Sons; 2003.
    1. Kelleher J, Humphrey CS, Homer D, Davison AM, Giles GR, Losowsky MS. Vitamin A and its transport proteins in patients with chronic renal failure receiving maintenance haemodialysis and after renal transplantation. Clin Sci (Lond) 1983;65:619–626. doi: 10.1042/cs0650619.
    1. Palleschi S, De Angelis S, Diana L, Rossi B, Papa V, Severini G, Splendiani G. Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study. Clin Chem Lab Med. 2007;45:1211–1218. doi: 10.1515/CCLM.2007.266.
    1. Gerardi G, Usberti M, Martini G, Albertini A, Sugherini L, Pompella A, Di Lorenzo D. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med. 2002;40:104–110. doi: 10.1515/CCLM.2002.019.
    1. Selmeci L. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? Free Radic Res. 2011;45:1115–1123. doi: 10.3109/10715762.2011.602074.
    1. Celik G, Yontem M, Cilo M, Bilge M, Mehmetoglu I, Unaldi M. The relationship between glutathione peroxidase and bioimpedance parameters in nondiabetic hemodialysis patients. Hemodial Int. 2012;16:274–281. doi: 10.1111/j.1542-4758.2011.00628.x.
    1. Susantitaphong P, Riella C, Jaber BL. Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis. Nephrol Dial Transplant. 2013;28:438–446. doi: 10.1093/ndt/gfs514.
    1. Stein G, Schone S, Geinitz D, Abendroth K, Kokot F, Funfstuck R, et al. No tissue level abnormality of vitamin A concentration despite elevated serum vitamin A of uremic patients. Clin Nephrol. 1986;25:87–93.
    1. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982;389:39–48. doi: 10.1111/j.1749-6632.1982.tb22124.x.
    1. Fleck A. Clinical and nutritional aspects of changes in acute-phase proteins during inflammation. Proc Nutr Soc. 1989;48:347–354. doi: 10.1079/PNS19890050.
    1. Baeten JM, Richardson BA, Bankson DD, Wener MH, Kreiss JK, Lavreys L, et al. Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response. Am J Clin Nutr. 2004;79:218–225.
    1. Koch A, Weiskirchen R, Sanson E, Zimmermann HW, Voigt S, Duckers H, et al. Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation. Crit Care. 2010;14:R179. doi: 10.1186/cc9285.
    1. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658. doi: 10.1046/j.1523-1755.1999.00273.x.
    1. Pedruzzi LM, Cardozo LF, Daleprane JB, Stockler-Pinto MB, Monteiro EB, Leite M, Jr, et al. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2. J Nephrol. 2015;28:495–501. doi: 10.1007/s40620-014-0162-0.
    1. Gerlach TH, Zile MH. Upregulation of serum retinol in experimental acute renal failure. FASEB J. 1990;4:2511–2517.
    1. Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database Syst Rev. 2015;5:CD006258.
    1. Woodside JV, Young IS, Gilchrist SE, Vioque J, Chakravarthy U, de Jong PT, et al. Factors associated with serum/plasma concentrations of vitamins A, C, E and carotenoids in older people throughout Europe: the EUREYE study. Eur J Nutr. 2013;52:1493–1501. doi: 10.1007/s00394-012-0456-8.
    1. Palace VP, Khaper N, Qin Q, Singal PK. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med. 1999;26:746–761. doi: 10.1016/S0891-5849(98)00266-4.
    1. Schunemann HJ, Grant BJ, Freudenheim JL, Muti P, Browne RW, Drake JA, et al. The relation of serum levels of antioxidant vitamins C and E, retinol and carotenoids with pulmonary function in the general population. Am J Respir Crit Care Med. 2001;163:1246–1255. doi: 10.1164/ajrccm.163.5.2007135.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する